The Center for Biosignal Research (CBR) focuses on the study and clinical use of biosignals, or signals that can be continuously measured and monitored from the human body. CBR brings together engineers, scientists, and clinicians across a range of disciplines to advance biosignal research, with emphasis on real-world clinical implementation and improving patient care. Our areas of research broadly focus on improving biosignal analysis through signal processing and advanced algorithms, identifying predictors of adverse outcomes, using biosignals to improve physiologic understanding and leveraging these insights to improve patient care and reduce false alarms in bedside monitoring. 

The CBR is based in the UCSF Division of Cardiology and the Cardiovascular Research Institute, and is part of the Berkeley/UCSF Computational Precision Health Program.